Dr. Claudia Steffal HCM, EMBA

Medical law studies, Johannes Kepler University, Linz

Executive MBA at the WU, Vienna

Academic Health Care Manager at WU, Vienna

Human medicine at the Medical University of Vienna

ÖAK diplomas: palliative care diploma, emergency doctor diploma, health resort doctor diploma, geriatrics diploma, substitution diploma, advanced training diploma ÖÄK, didactics diploma

Specialist in Radiation Oncology, MedAustron

Primaria at the Institute for Radiooncology at the Favoriten Clinic

Risk Manager

Auditor for DOC-Zert

Tutor for assistant doctors

Specialist coordinator and mentor

Visiting professor at the Medical University of Vienna

Senior hospital physician for radiation oncology

Specialist in radiotherapy and radiooncology and general practitioner

Member of ÖGRO

Member of SANO

Member of ESTRO

Member of ISRS

Member of ÖGS

Member of ASTRO

Member of IORBC

Durvalumab prolongs overall survival. Whereas radiation dose escalation > 66 Gy might improve long-term local control in unresectable NSCLC Stage III: Updated Analysis of the Austrian Radiooncological Lung Cancer Study Association Rgistry (ALLSTAR)F. Zehentmayr, P. Feurstein, E. Ruznic, …C. Steffal, …K.Dieckmann; Cancers, April 2025

157P Durvalumab impacts progression-free survival but not local
control in patients with inoperable NSCLC stage III: Real-world
data from the Austrian radio-oncological lung cancer study
association registry (ALLSTAR)
F. Zehentmayr, P. Feurstein, E. Ruznic, …C. Steffal, …K. Dieckmann; ESMO open, March 2024

Durvalumab impacts PFS while high-dose radiation > 66 Gy
improves LC without excess toxicity in unresectable NSCLC stage
III: Real-world data from Austrian radio-oncological lung cancer
study association registry (ALLSTAR)
F. Zehentmayr, P. Feurstein, E. Ruznic, …C. Steffal, …K.
Dieckmann; Radiotherapy und Oncology July 2024; 196: 110294

Stereotactic radiosurgery and radiotherapy for resected brain
metastases: current pattern of care in the Radiosurgery and
Stereotactic Radiotherapy Working Group of the German
Association for Radiation Oncology (DEGRO)
S. Rogers, B.G. Baumert, O.Blanck, ….C. Steffal, …S.E. Combs; Strahlentherapie und Onkologie 2022; 198(1)

5 years of experience with DIBH (Deep inspiration breath-hold)
combined with SGRT (Surface-Guided Radiation Therapy) in leftsided breast cancer
C. Steffal, A.U. Schratter-Sehn, K. Brinda-Raitmayr, T. Kann, D. Mailat, J. Reiterer, G. Tremmel; Senologie 2020; 17: 1–9

The course of quality of life and neurocognition in newly
diagnosed patients with glioblastoma
B. Flechl, C. Sax, M. Ackerl, R. Crevenna, …C. LütgendorfCaucig, K. Dieckmann, C. Steffal, C. Marosi …; Radiother Oncol. 2017 Nov; 125(2):228-233. doi: 10.1016/j.radonc.2017.07.027. Epub 2017 Aug 8